- Academic staff
- Dr Frank Baganz
- Dr Daniel Bracewell
- Prof Paul Dalby
- Professor Suzanne Farid
- Prof Michael Hoare
- Prof Eli Keshavarz-Moore
- Dr Alex Kiparissides
- Prof Gary Lye
- Prof Chris Mason
- Dr Martina Micheletti
- Dr Tarit Mukhopadhyay
- Dr Darren Nesbeth
- Dr Brenda Parker
- Dr Sofia Simaria
- Professor Nicolas Szita
- Prof Nigel Titchener-Hooker
- Professor Ajoy Velayudhan
- Dr Farlan Veraitch
- Dr Ivan Wall
- Prof John Ward
- Dr Yuhong Zhou
- Research and Facilities
- Research Associates
- Professional Services
- Academic staff
Professor Chris Mason
Professor of Regenerative Medicine Bioprocessing
- GMC registered medical practitioner
- Fellow of the Royal College of Surgeons of England (FRCS)
- Fellow of the Royal College of Surgeons in Ireland (FRCSI)
- Fellow of Royal Society of Medicine plus Member of Council of the Medical Genetics Section
- Member of the Royal Institution of Great Britain
- Medical Research Council Clinical Research Fellow (October 1999 - August 2002)
- Overall Winner - Medical Futures Innovation Awards, Medical Futures Innovation Awards. Award sponsor: NESTA (2002)
- Winner - Best Biotech Start-Up Innovation Award, Medical Futures Innovation Awards, Award sponsor: Accenture (2002)
- Stem Cell Clinical Liaison Committee Member, MRC (2003 to present)
- Measurement Advisory Committee Working Group - The Measurement for Emerging Technologies (MET) Programme (a National Measurement System [NMS] Programme) (January 2004 - June 2007)
- Cofounder with Dr. Stephen Minger (King’s College London), London Regenerative Medicine Network (May 2005 - present)
- Cofounder and Senior Editor, “Regenerative Medicine” journal (October 2005 - present)
- Oral and written evidence to the UK Stem Cell Initiative (UKSCI) chaired by Sir John Pattison (December 2005)
- Steering Committee Member DTI/British Standards Institute (BSi) - PAS 83 - “Guidance on standards, standardised methods and regulation for cell-based therapeutics, from basic research to clinical application” (March 2005 - November 2006)
- Editorial Board, “Nanomedicine” journal (August 2006 - present)
- Editorial Advisory Board, “Medical Device Technology” journal (May 2006 - present)
- Advisory Panel, University of Nottingham - MSc Stem Cell Technology Course - (September 2006 - present)
- Winner of “ Outstanding Contribution to London Biotechnology” - London Biotechnology Network (2006) - Award shared with Dr. Stephen Minger (King’s College London)
- Committee Member, Engineering & Biological Systems (EBS), BBSRC (October 2006 - present)
- Steering Committee Member, UK National Stem Cell Network (UKNSCN) (December 2006 - present)
- Royal Institution of Great Britain, Friday Evening Discourse, “Therapeutic potential of human stem cells: promise and pitfalls” (February 2007)
- Advisor, Canadian National Stem Cell Network (2007)
- Editorial Board, “Tissue Engineering” journal (January 2007 - present)
- Scientific Advisory Board, Blond McIndoe Research Foundation (October 2007 - present)
- The Hunterian Lecture, “Stem cells and tissue engineering - Hope or hype?“, Hunterian Society, London (November 2007)
- Chair of Management Committee, Regenerative Medicine EPSRC Life Science Doctoral Training Centre - Collaboration between the universities of Loughborough, Keele and Nottingham (2007 – present)
Awaiting server response...
Teaching and Training Activities
Within the Department, Mason has taken the lead role on the provision of stem cell and regenerative medicine bioprocessing teaching at all levels i.e. undergraduate, masters, postdoc and industry. Thus providing the essential teaching base for skilled bioprocessing engineers underpinning the regen industry.
Part of Mason’s teaching contribution is to direct all the stem cell and regenerative medicine bioprocessing aspects of the fourth year MEng programme including two courses. The first MEng course unit introduces students to advanced biochemical engineering and bioprocessing skills and in particular the ability to take fundamental stem cell science concepts and identify how best to translate them into real clinical outcomes. This allows students with engineering design skills to address an activity that will need novel approaches if robust, cost effective and safe cell therapies are to be available. Likewise, Mason has also established an MEng course unit which introduces the students to the latest basic science behind the next generation of regenerative medicine therapies with a view to their potential impact and challenges for biochemical engineering.
Together with Dr. Karen Smith and Dr. Farlan Veraitch, a new MBI module, “Stem Cells and Regenerative Medicine Bioprocessing” has been established. This course focuses on all aspects of whole bioprocessing including both universal (allogeneic) and patient specific (autologous) cell therapies plus tissue engineering and is taught by a team of internationally recognised industry experts. In addition, important related topics such as regulation and ethics from the commercial perspective are also covered.
A Masters level enterprise course for the Department’s full time MSc and doctoral students has been established in collaboration with Dr. Eli Keshavarz-Moore and Dr. Bill Hornby. Focusing on real case studies from the world of stem cells and regenerative medicine, the MSc and doctoral students, through a number of workshops and other activities, prepare in-depth business plans and presentations.
Mason also contributes to a first year undergraduate course aimed at encouraging students to realise the great value of biochemical engineering and its role in healthcare and society.
A major organisational requirement of the Department’s teaching and tutoring activities is to enable engineering students to acquire life science expertise. The Department strongly believes that this is best achieved by integrating the students with life scientists on their specialist courses and then providing the tutorial linkage to help guide the students. Mason heads up the departmental review group which meets with life science colleagues to oversee how best to address this rapidly developing area.
Mason is responsible for developing the stem cell and regenerative medicine bioprocessing activity of the EPSRC Engineering Doctorate (EngD) in Bioprocess Leadership Programme which is overall directed by Prof. Nigel Titchener-Hooker. Cell therapy and regenerative medicine companies/organisations which have already signed up to the scheme include; Axordia, Linkam Scientific, NIBSC, Moorfields Eye Hospital, Onyvax, Plasticell, Smith & Nephew, The Automation Partnership and the UK Stem Cell Bank.
Page last modified on 06 nov 13 13:21